Company Description
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China.
It operates in two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers.
It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, sexual wellness products, and baby products.
The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services.
In addition, it offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services.
The company operates offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangdong, Guangzhou, Tianjin, and Kunshan.
It serves pharmacies, pharmaceutical companies, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018.
111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
| Country | China |
| Founded | 2010 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 1,520 |
| CEO | Junling Liu |
Contact Details
Address: No.295 ZuChongZhi Road, 3-4 Floors Shanghai, 201203 China | |
| Phone | 86 21 2053 6666 |
| Website | corporate.111.com.cn |
Stock Details
| Ticker Symbol | YI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| CIK Code | 0001738906 |
| CUSIP Number | 68247Q102 |
| ISIN Number | US68247Q1022 |
| SIC Code | 5912 |
Key Executives
| Name | Position |
|---|---|
| Junling Liu | Co-Founder, Acting Chief Financial Officer, Chairman and Chief Executive Officer |
| Dr. Gang Yu Ph.D. | Co-Founder and Executive Chairman |
| Haihui Wang | Co-Chief Operating Officer |
| Pengcheng Zhu | Co-Chief Operating Officer |
| Monica Mu | IR Director |
| Anfeng Guo | Chief Innovation Officer |
| Alex Liu | Finance Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 27, 2024 | 6-K | Report of foreign issuer |
| Nov 4, 2024 | 6-K | Report of foreign issuer |
| Aug 29, 2024 | 6-K | Report of foreign issuer |
| Jul 19, 2024 | 6-K | Report of foreign issuer |
| May 23, 2024 | 6-K | Report of foreign issuer |
| May 14, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Apr 30, 2024 | NT 20-F | Notification of inability to timely file Form 20-F |
| Mar 21, 2024 | 6-K | Report of foreign issuer |
| Feb 27, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Feb 27, 2024 | 6-K | Report of foreign issuer |